Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Kindred Biosciences, Inc. | exhibit321-201710k.htm |
| EX-31.2 - EXHIBIT 31.2 - Kindred Biosciences, Inc. | exhibit312-201710k.htm |
| EX-31.1 - EXHIBIT 31.1 - Kindred Biosciences, Inc. | exhibit311-201710k.htm |
| EX-21.1 - EXHIBIT 21.1 - Kindred Biosciences, Inc. | exhibit211listofsubsidaries.htm |
| EX-10.21 - EXHIBIT 10.21 - Kindred Biosciences, Inc. | exhibit1019-secondleaseadd.htm |
| EX-10.20 - EXHIBIT 10.20 - Kindred Biosciences, Inc. | exhbit1018-officeleaseadde.htm |
| EX-10.8 - EXHIBIT 10.8 - Kindred Biosciences, Inc. | exhibit108-2016equityincen.htm |
| 10-K - 10-K - Kindred Biosciences, Inc. | kindredbio201710-k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-193039, 333-200687 and 333-211839 on Form S-8 and Registration Statement Nos. 333-201553 and 333-222597 on Form S-3 of our report dated March 1, 2018, relating to the consolidated financial statements of Kindred Biosciences, Inc. and Subsidiary appearing in this Annual Report on Form 10-K of Kindred Biosciences, Inc. for the year ended December 31, 2017.
/s/ KMJ Corbin & Company LLP
Costa Mesa, California
March 1, 2018